Dr. Tolga Sütlü received his B.Sc. in Biological Sciences and Bioengineering from Sabanci University and his Ph.D. in Medical Science from Karolinska Institutet. After his postdoctoral work in Karolinska University Hospital, he returned to Turkey to start his research at Sabanci University. He was a faculty member at the Department of Molecular Biology and Genetics of Boğaziçi University and became as an Assistant Professor position at Acibadem University. He focuses on cancer immunology, immunotherapy and also personalized medicine, with targeting of immune system cells to cancer tissue through ex vivo propagation and genetic modification. He is an executive board member at the Turkish Society of Immunology since 2016. He is a founding partner of the US-based immunotherapy company Vycellix.